Back to Search
SAMUEL MOLICA, DO
DO
Surgery Physician
NPI: 1750792511IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
307328(NY)
CMS Specialties
PrimaryGENERAL SURGERY
Education
MIDWESTERN UNIVERSITY, CHICAGO COLLEGE OF OSTEOPATHIC MED
Class of 2014
Research & Publications (20)
Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
PMID 15182336·Eur J Haematol·2004
8-other
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.
PMID 19406724·Clin Lymphoma Myeloma·2009
3-trial
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.
PMID 19438486·Br J Haematol·2009
4-observational
CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL.
PMID 19247978·Hematol Oncol·2009
8-other
Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages.
PMID 19483161·Haematologica·2009
8-other
Serum level of CD26 predicts time to first treatment in early B-chronic lymphocytic leukemia.
PMID 19459926·Eur J Haematol·2009
8-other
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia.
PMID 18556064·Leuk Res·2009
8-other
Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
PMID 18818986·Int J Hematol·2008
8-other
Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemia.
PMID 18203013·Leuk Lymphoma·2008
8-other
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.
PMID 17667938·Oncogene·2008
8-other
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
PMID 18521849·Genes Chromosomes Cancer·2008
8-other
Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making.
PMID 18555682·Eur J Cancer·2008
1-meta
Immunomodulatory drugs in chronic lymphocytic leukemia: a new treatment paradigm.
PMID 17487728·Leuk Lymphoma·2007
6-review
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.
PMID 17485110·Leuk Res·2007
8-other
Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia.
PMID 17768114·Haematologica·2007
3-trial
Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
PMID 16840194·Leuk Lymphoma·2006
8-other
Sex differences in incidence and outcome of chronic lymphocytic leukemia patients.
PMID 16966256·Leuk Lymphoma·2006
6-review
Second neoplasms in chronic lymphocytic leukemia: Are case-group studies useful?
PMID 17107892·Leuk Lymphoma·2006
8-other
Characteristics and outcome of B-cell chronic lymphocytic leukemia in hepatitis C virus-positive patients.
PMID 17107922·Leuk Lymphoma·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
2.5(210)
- Address
- 1500 N JAMES ST
ROME, NY 13440 - Phone
- (315) 338-7184
- Website
- romehealth.org
2.5(210)
See full reviewsQuick Facts
- NPI
- 1750792511
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile